Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations

NHS Foundation Trust

Status: Completed

Conditions: Diabetes Mellitus

Treatments: Drug: Sulfonylurea

Study type: Interventional

Funder types: Other

Identifiers

NCT00334711

97/29/AH/mbs NTNU

Jnr 207/mkd NTNU

2003/10/196

CCPPRB Necker GLIDKIR6.2

Details and patient eligibility

About

The purpose of this study is to investigate whether patients with diabetes due to Kir6.2 mutations can be treated with sulfonylurea medication rather than insulin, and if this is the case to investigate the mechanism for sulfonylurea response.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diabetes due to KCNJ11 (Kir6.2) mutation

Exclusion criteria

• None

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)